The Dow has been less-than-ideally balanced for a while without most investors even realizing it. Energy name Chevron will still be a Dow component, and given that the oil and gas industry may never again be what it once was, one such name may be enough. Pfizer will be taken out of the DJIA, but drug company Merck remains. There's no biotech/biopharma stock of Amgen's ilk in the Dow right now, but there arguably should be. Perhaps most ironic is that, without the impending addition of Honeywell, there would still be no factory-centered industrial name in the Dow Jones Industrial Average.

Source: Daily Sun August 27, 2020 12:33 UTC